| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1B | $5.9B | $6.6B | $11.2B | $6.5B | $4.1B | $1.0B | $1.1B |
| Cost of Revenue | $4.4B | $3.9B | $4.1B | $5.3B | $4.2B | $3.3B | $3.4B | — |
| Gross Profit | $2.7B | $2.1B | $2.5B | $5.9B | $2.4B | $0.8B | $0.2B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Operating Income | $2.3B | $1.7B | $2.2B | $5.4B | $1.7B | $0.6B | $1.0B | $1.2B |
| Net Income | $1.8B | $1.5B | $1.8B | $3.9B | $1.3B | $0.4B | $0.1B | $0.7B |
| EPS (Basic) | $8.98 | $6.75 | $7.89 | $16.45 | $4.27 | $1.48 | $0.26 | $0.11 |
| EPS (Diluted) | $8.97 | $6.74 | $7.87 | $16.38 | $4.24 | $1.47 | $0.25 | $0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.1B | $13.5B | $14.4B | $13.3B | $12.4B | $12.0B | $12.2B | $12.7B |
| Current Assets | $3.0B | $2.5B | $3.0B | $3.7B | $2.6B | $1.4B | $1.0B | $1.1B |
| Cash & Equivalents | $0.6B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.3B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.9B | $0.8B | $0.8B | $1.0B | $1.4B | $0.9B | $0.7B | $1.2B |
| Stockholders' Equity | $4.8B | $5.0B | $5.7B | $5.1B | $3.2B | $2.9B | $2.9B | $4.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.8B | $2.3B | $2.8B | $3.9B | $2.9B | $1.2B | $1.5B | — |
| Investing Cash Flow | $-0.9B | $-0.5B | $-1.7B | $-0.4B | $-0.5B | $-0.3B | $-0.3B | — |
| Capital Expenditures | $0.9B | $0.5B | $0.5B | $0.5B | $0.5B | $0.3B | $0.4B | $2.5B |
| Financing Cash Flow | $-1.5B | $-2.2B | $-1.4B | $-2.7B | $-1.5B | $-0.5B | $-1.6B | — |